HIGHLIGHTS
- who: YTHDF et al. from the Yat-sen University, China have published the Article: Pan-cancer analysis identi es YTHDF2 as an immunotherapeutic and prognostic biomarker, in the Journal: (JOURNAL)
- how: To further explore the predictive value of YTHDF2 for the prognosis of patients with LIHC KIRC KICH ACC LGG READ SARC and CHOL the authors conducted the ROC analysis and found that YTHDF2 had a better predictive ability for the prognosis of patients with CHOL KICH LGG and READ and a good predictive ability for patients with LIHC . The above results indicated that the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.